Victory Capital Management
MRNS

Victory Capital Management’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Victory Capital Management’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-61,220
Closed -$553K – 2558
2024
Q1 		$553K Sell
61,220
-22,050
-26% -$214K ﹤0.01% 1953
2023
Q4 		$905K Sell
83,270
-11,280
-12% -$84.5K ﹤0.01% 1765
2023
Q3 		$761K Buy
94,550
+35,890
+61% +$299K ﹤0.01% 1799
2023
Q2 		$637K Buy
+58,660
New +$502K ﹤0.01% 1882
2022
Q3 		– Sell
-113,779
Closed -$551K – 2797
2022
Q2 		$551K Hold
113,779
– – ﹤0.01% 2011
2022
Q1 		$1.06M Buy
113,779
+15,930
+16% +$158K ﹤0.01% 1782
2021
Q4 		$1.16M Sell
97,849
-4,420
-4% -$51K ﹤0.01% 1773
2021
Q3 		$1.16M Buy
102,269
+7,190
+8% +$98.9K ﹤0.01% 1793
2021
Q2 		$1.71M Buy
95,079
+3,520
+4% +$56.6K ﹤0.01% 1683
2021
Q1 		$1.42M Buy
91,559
+6,330
+7% +$91.6K ﹤0.01% 1750
2020
Q4 		$1.04M Sell
85,229
-13,880
-14% -$193K ﹤0.01% 1769
2020
Q3 		$1.27M Sell
99,109
-6,418
-6% -$55.4K ﹤0.01% 1600
2020
Q2 		$1.07M Buy
105,527
+99,070
+1,534% +$911K ﹤0.01% 1702
2020
Q1 		$52K Buy
+6,457
New +$55.9K ﹤0.01% 2749
2019
Q4 		– Sell
-2,011
Closed -$12K – 3403
2019
Q3 		$12K Buy
+2,011
New +$16.2K ﹤0.01% 3201

Other funds holding MRNS

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management's MRNS Position: Q2 2024 in Review

Victory Capital Management sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q2 2024, closing a stake of 61,220 shares — an estimated $553K sold.

Victory Capital Management first reported a position in MRNS in Q3 2019 and held it in 15 quarters. The position peaked at $1.71M in Q2 2021. 90 funds tracked by Wall St. Rank hold MRNS as of Q2 2024.

  • Victory Capital Management reported no remaining Marinus Pharmaceuticals, Inc position as of Q2 2024 after selling out during the quarter.
  • Victory Capital Management sold 61,220 Marinus Pharmaceuticals, Inc shares in Q2 2024, an estimated $553K.
  • Victory Capital Management first reported a position in Marinus Pharmaceuticals, Inc in Q3 2019 and held it in 15 quarters.
  • Victory Capital Management's Marinus Pharmaceuticals, Inc position peaked at $1.71M in Q2 2021.
  • 90 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q2 2024.

Based on Victory Capital Management's 13F filing for Q2 2024, filed 5 Aug 2024.